Developing and commercializing therapeutics for infectious and orphan diseases
Viropharma was originally an anti-viral therapeutics discovery and development company that eventually became one of the leading specialty pharmaceutical companies focusing on a range of orphan and infectious diseases. Viropharma completed its IPO in 1996 and was acquired by Shire in 2013.